Sumitomo Chemical India Ltd

Sumitomo Chemical India Ltd

₹ 505 -1.19%
11 Jun - close price
About

Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1] [2]

Key Points

Products
The company operates in various product segments, including insecticides, weedicides, fungicides, fumigants, rodenticides, plant growth nutrition products, bio-rationals, and plant growth regulators. It markets proprietary products from its Japanese parent, Sumitomo Chemical Co., in agrochemicals, animal nutrition, and environmental health.[1]

The products comprise conventional chemistry sourced from SCC, and biological products sourced from a USA-based subsidiary, Valent Biosciences LLC. [2]

  • Market Cap 25,185 Cr.
  • Current Price 505
  • High / Low 628 / 446
  • Stock P/E 50.2
  • Book Value 58.0
  • Dividend Yield 0.18 %
  • ROCE 25.1 %
  • ROE 18.8 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 37.5%

Cons

  • Stock is trading at 8.70 times its book value
  • The company has delivered a poor sales growth of 4.98% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
664 986 1,122 753 652 724 903 540 664 832 971 622 665
555 798 843 632 571 643 715 474 526 670 729 521 548
Operating Profit 109 188 278 121 81 81 188 66 139 162 242 101 117
OPM % 16% 19% 25% 16% 12% 11% 21% 12% 21% 19% 25% 16% 18%
7 5 11 13 17 18 25 27 27 26 31 31 31
Interest 1 1 1 1 1 1 1 1 1 1 1 1 1
Depreciation 11 11 15 11 14 14 16 16 16 14 15 18 16
Profit before tax 104 180 272 121 82 83 196 76 149 173 257 113 132
Tax % 28% 23% 26% 25% 12% 26% 27% 27% 26% 26% 26% 25% 25%
75 138 202 91 72 62 144 55 109 128 191 84 98
EPS in Rs 1.50 2.77 4.05 1.82 1.45 1.24 2.88 1.10 2.19 2.57 3.82 1.69 1.97
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
635 671 724 799 1,911 2,223 2,423 2,643 3,060 3,511 2,833 3,090
587 614 635 698 1,691 1,932 2,088 2,155 2,458 2,843 2,358 2,468
Operating Profit 48 57 89 101 219 291 335 488 603 668 474 623
OPM % 8% 8% 12% 13% 11% 13% 14% 18% 20% 19% 17% 20%
3 8 26 10 31 -0 -20 19 36 45 96 119
Interest 2 1 1 1 5 5 7 7 8 6 5 5
Depreciation 6 6 7 7 24 28 41 47 45 52 61 63
Profit before tax 43 58 107 103 221 258 267 453 586 655 503 674
Tax % 23% 40% 40% 40% 34% 35% 23% 24% 26% 23% 27% 26%
33 35 65 62 145 167 206 345 434 503 370 502
EPS in Rs 4.12 6.92 8.69 10.09 7.41 10.06
Dividend Payout % 0% 0% 0% 0% 0% 38% 18% 12% 12% 12% 80% 21%
Compounded Sales Growth
10 Years: 17%
5 Years: 5%
3 Years: 0%
TTM: 9%
Compounded Profit Growth
10 Years: 31%
5 Years: 17%
3 Years: 5%
TTM: 36%
Stock Price CAGR
10 Years: %
5 Years: 12%
3 Years: 3%
1 Year: 4%
Return on Equity
10 Years: 20%
5 Years: 21%
3 Years: 19%
Last Year: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 233 233 233 275 275 275 499 499 499 499 499 499
Reserves -36 -2 63 360 665 761 710 1,029 1,425 1,881 1,941 2,397
0 0 0 0 10 20 36 33 38 34 25 45
243 234 280 288 695 791 848 1,097 1,047 955 822 988
Total Liabilities 440 466 576 922 1,644 1,846 2,093 2,658 3,009 3,368 3,287 3,930
47 51 52 53 267 279 319 309 390 430 489 501
CWIP 0 0 1 7 9 8 10 14 35 71 23 9
Investments 0 0 0 277 2 1 87 291 357 239 425 601
393 415 523 585 1,367 1,558 1,676 2,043 2,227 2,628 2,351 2,819
Total Assets 440 466 576 922 1,644 1,846 2,093 2,658 3,009 3,368 3,287 3,930

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
20 4 52 -21 49 75 222 424 223 389 756 459
-8 -8 -5 -289 -40 -35 -118 -282 -281 -327 -426 -404
-1 0 -0 276 7 -65 -61 -47 -63 -73 -331 -66
Net Cash Flow 11 -4 47 -34 16 -26 43 95 -120 -10 -1 -11

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 90 83 92 101 105 110 128 117 101 98 91 90
Inventory Days 125 135 169 191 202 193 133 185 198 157 135 138
Days Payable 134 109 132 115 176 136 112 145 110 87 96 97
Cash Conversion Cycle 81 109 130 177 131 167 150 157 189 168 131 132
Working Capital Days 58 69 79 113 115 119 111 97 128 138 175 239
ROCE % 25% 27% 41% 22% 29% 27% 26% 33% 34% 30% 21% 25%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00%
1.90% 2.05% 2.44% 2.40% 2.51% 2.58% 2.61% 2.74% 3.06% 3.49% 3.59% 3.63%
6.70% 6.39% 5.52% 5.50% 5.50% 6.06% 6.02% 6.63% 7.13% 6.96% 6.96% 8.13%
16.40% 16.54% 17.02% 17.09% 16.96% 16.33% 16.35% 15.61% 14.79% 14.54% 14.44% 13.23%
No. of Shareholders 1,33,6581,46,0631,44,0181,42,5961,56,1361,47,9071,45,0831,48,7641,28,1481,24,8571,25,8121,24,650

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls